| PDBbind Data Link | Affinity_Quilifier | Kd | PubMed | Protein Target | Protein Name | MMDB | PDB |
|---|---|---|---|---|---|---|---|
| http://www.pdbbind.org.cn/quickpdb.asp?quickpdb=1a1e | = | 1 | 9174343 | 1A1E_B | tyrosine kinase C-src | 73432 | 1A1E |
| http://www.pdbbind.org.cn/quickpdb.asp?quickpdb=1a7c | <= | 100 | 9634700 | 1A7C_A | plasminogen activator inhibitor type 1 | 97714 | 1A7C |
| http://www.pdbbind.org.cn/quickpdb.asp?quickpdb=1adl | = | 4.4 | 7929228 | 1ADL_A | trp rna-binding attenuation protein | 55147 | 1ADL |
| http://www.pdbbind.org.cn/quickpdb.asp?quickpdb=1ado | = | 1 | 8989320 | 1ADO_A | fructose 1,6-bisphosphate aldolase | 6825 | 1ADO |
| http://www.pdbbind.org.cn/quickpdb.asp?quickpdb=1af6 | = | 15000 | 9299337 | 1AF6_A,1AF6_B | maltoporin | 7612 | 1AF6 |
| http://www.pdbbind.org.cn/quickpdb.asp?quickpdb=1ag9 | = | 0.001 | 9416602 | 1AG9_A | flavodoxin | 6827 | 1AG9 |
| http://www.pdbbind.org.cn/quickpdb.asp?quickpdb=1ahx | = | 120 | 7664122 | 1AHX_A,1AHX_B | aspartate aminotransferase | 3769 | 1AHX |
| http://www.pdbbind.org.cn/quickpdb.asp?quickpdb=1ahy | = | 440 | 7664122 | 1AHY_A,1AHY_B | aspartate aminotransferase | 3768 | 1AHY |
| http://www.pdbbind.org.cn/quickpdb.asp?quickpdb=1aj6 | = | 1.2 | 9245398 | 1AJ6_A | DNA gyrase b | 55222 | 1AJ6 |
| http://www.pdbbind.org.cn/quickpdb.asp?quickpdb=1aj7 | = | 135 | 9180069 | 1AJ7_L,1AJ7_H | immunoglobulin 48g7 germline fab | 6588 | 1AJ7 |
| http://www.pdbbind.org.cn/quickpdb.asp?quickpdb=1akq | = | 7.9E-4 | 9874201 | 1AKQ_A | flavodoxin | 55243 | 1AKQ |
| http://www.pdbbind.org.cn/quickpdb.asp?quickpdb=1akr | = | 8.2E-4 | 9622492 | 1AKR_A | flavodoxin | 55244 | 1AKR |
| http://www.pdbbind.org.cn/quickpdb.asp?quickpdb=1akt | = | 0.0032 | 9622492 | 1AKT_A | flavodoxin | 55245 | 1AKT |
| http://www.pdbbind.org.cn/quickpdb.asp?quickpdb=1aku | = | 0.746 | 1AKU_A | flavodoxin | 55246 | 1AKU | |
| http://www.pdbbind.org.cn/quickpdb.asp?quickpdb=1akv | = | 2.6E-6 | 1AKV_A | flavodoxin | 55247 | 1AKV | |
| http://www.pdbbind.org.cn/quickpdb.asp?quickpdb=1akw | = | 0.0026 | 9622492 | 1AKW_A | flavodoxin | 55248 | 1AKW |
| http://www.pdbbind.org.cn/quickpdb.asp?quickpdb=1amw | = | 29 | 9230303 | 1AMW_A | heat shock protein 90 | 55278 | 1AMW |
| http://www.pdbbind.org.cn/quickpdb.asp?quickpdb=1ao0 | = | 11 | 9271502 | 1AO0_A,1AO0_B | glutamine phosphoribosylpyrophosphate | 6600 | 1AO0 |
| http://www.pdbbind.org.cn/quickpdb.asp?quickpdb=1apb | = | 1.51 | 2204627 | 1APB_A | apolipoprotein | 55308 | 1APB |
| http://www.pdbbind.org.cn/quickpdb.asp?quickpdb=1aqi | = | 2.4 | 8995524 | 1AQI_A | adenine-n6-dna-methyltransferase taqi | 5182 | 1AQI |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.0000040000 uM | Activity at 0.0000163452 uM | Activity at 0.0000320000 uM | Activity at 0.0000806082 uM | Activity at 0.0001439601 uM | Activity at 0.0003895389 uM | Activity at 0.0007288991 uM | Activity at 0.00154 uM | Activity at 0.00290 uM | Activity at 0.00454 uM | Activity at 0.00833 uM | Activity at 0.021 uM | Activity at 0.041 uM | Activity at 0.095 uM | Activity at 0.199 uM | Activity at 0.321 uM | Activity at 0.689 uM | Activity at 1.028 uM | Activity at 2.684 uM | Activity at 5.101 uM | Activity at 10.05 uM | Activity at 24.85 uM | Activity at 39.21 uM | Activity at 78.39 uM | Activity at 125.0 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inactive | 0 | 0 | 0 | 4 | 58.4116 | 43.5916 | 25.8843 | 33.4207 | 9.1109 | 21.6395 | 45.6886 | 10.8911 | 28.3955 | 31.3127 | 38.9914 | 41.6558 | 58.4116 | QC'd by Sytravon | |||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -12.6805 | -10.7548 | -9.5107 | -10.6418 | -15.9997 | -12.6805 | QC'd by Sytravon | ||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -7.1462 | -9.2235 | -11.8601 | -6.118 | -12.2196 | -7.1462 | QC'd by Sytravon | ||||||||||||||||||||||||||||
| Inactive | 0 | -4.75 | 4.9549 | 0.6661 | -22.0013 | -2 | 4 | 0 0 0 0 0 | -18.751 | -10.987 | -0.9935 | 2.356 | 1.2583 | -18.751 | QC'd by Sytravon | ||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -11.1249 | -10.2692 | -11.5229 | -11.032 | -13.325 | -11.1249 | QC'd by Sytravon | ||||||||||||||||||||||||||||
| Inactive | 0 | -4.8 | 1.8851 | 0.5555 | -23.9168 | -5.4088 | 4 | 0 0 0 0 0 | -18.264 | -13.0121 | -2.8407 | -6.6548 | -7.1687 | -18.264 | QC'd by Sytravon | ||||||||||||||||||||||||
| Inactive | 0 | -6.35 | 4.9549 | 0.9083 | -3.1815 | -14.9283 | 4 | 0 0 0 0 1 | -10.2909 | -13.1276 | -17.0236 | -1.4012 | -4.6174 | -10.2909 | QC'd by Sytravon | ||||||||||||||||||||||||
| Inactive | 0 | -5.95 | 0.4 | 0.9812 | -20.7272 | -0.9942 | 4 | 0 0 0 0 0 | -16.0227 | -4.9952 | -8.1266 | -9.7286 | -14.3153 | -16.0227 | QC'd by Sytravon | ||||||||||||||||||||||||
| Inactive | 0 | -6.5 | 4.9549 | 0.6409 | -9.2158 | -16.6011 | 4 | 0 0 0 0 1 | -12.7654 | -16.3342 | -16.1896 | -6.0131 | -13.084 | -12.7654 | QC'd by Sytravon | ||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 1.975 | 2.6103 | 3.4198 | -3.4748 | 1.7624 | 1.975 | QC'd by Sytravon | ||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -8.2223 | -0.1456 | -4.3339 | -1.582 | -3.6253 | -8.2223 | QC'd by Sytravon | ||||||||||||||||||||||||||||
| Inactive | 0 | -7.25 | 4.9549 | 0.602 | -10.0715 | 2 | 4 | 0 0 0 0 0 | -12.6011 | 0.2325 | -14.2262 | -4.5441 | -8.7364 | -12.6011 | QC'd by Sytravon | ||||||||||||||||||||||||
| Inactive | 0 | -4.75 | 4.5045 | 0.9809 | -24.6554 | -10.8442 | 4 | 0 0 0 0 0 | -22.2129 | -9.8702 | -10.3098 | -11.7375 | -10.6121 | -22.2129 | QC'd by Sytravon | ||||||||||||||||||||||||
| Inactive | 0 | -4.75 | 4.9549 | 0.8409 | -13.5514 | 2 | 4 | 0 0 0 0 0 | -11.2928 | -1.9276 | 4.6106 | 1.3336 | 4.0275 | -11.2928 | QC'd by Sytravon | ||||||||||||||||||||||||
| Inactive | 0 | -5.2 | 0.5 | 0.9077 | -28.8252 | -9.4452 | 4 | 0 0 0 0 0 | -23.1876 | -10.7877 | -12.0613 | -16.7104 | -16.3414 | -23.1876 | QC'd by Sytravon | ||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -18.3436 | -16.2788 | -21.7212 | -19.8613 | -16.6894 | -18.3436 | QC'd by Sytravon | ||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -5.4025 | -9.518 | -0.1694 | 0.2848 | -4.8162 | -5.4025 | QC'd by Sytravon | ||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -23.1229 | -14.0834 | -13.5556 | -16.7644 | -18.8145 | -23.1229 | QC'd by Sytravon | ||||||||||||||||||||||||||||
| Inactive | 0 | -4.95 | 3.2975 | 0.9426 | -35.5663 | -15.2262 | 4 | 0 0 0 0 0 | -34.2687 | -12.6885 | -18.3414 | -14.0693 | -16.4909 | -34.2687 | QC'd by Sytravon | ||||||||||||||||||||||||
| Inactive | 0 | -4.75 | 4.9549 | 0.7952 | -15.6253 | -4.8932 | 4 | 0 0 0 0 0 | -13.8544 | -4.3645 | -8.5252 | -3.661 | -3.9903 | -13.8544 | QC'd by Sytravon |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.00457 uM | Activity at 0.023 uM | Activity at 0.046 uM | Activity at 0.104 uM | Activity at 0.151 uM | Activity at 0.229 uM | Activity at 0.457 uM | Activity at 0.573 uM | Activity at 0.907 uM | Activity at 1.145 uM | Activity at 2.290 uM | Activity at 3.065 uM | Activity at 5.336 uM | Activity at 6.860 uM | Activity at 11.40 uM | Activity at 15.33 uM | Activity at 26.44 uM | Activity at 34.30 uM | Activity at 57.10 uM | Activity at 85.70 uM | Activity at 114.5 uM | Activity at 171.0 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inactive | 0 | 0 | 0 | 4 | -4.2348 | 0 | 0 | 0 | -4.2348 | QC'd by SIGMA | ||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 0 | 0 | 0 | 0 | 0 | QC'd by SIGMA | ||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 0 | 0 | 0 | 0 | 0 | QC'd by FLUKA | ||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 0.2955 | -8.4544 | -0.0719 | 0 | 0.2955 | QC'd by SigmaAldrich | ||||||||||||||||||||||||||
| Inactive | 0 | -4.35 | 4.9549 | 0.7922 | -9.2389 | 1.5 | 4 | 0 0 0 0 | -6.8657 | 0 | 0 | 4.5852 | -6.8657 | QC'd by SIGMA | ||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 1.8364 | 0 | 0 | 2.72 | 1.8364 | QC'd by Labotest | ||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 1.8575 | 0 | 0 | 4.5518 | 1.8575 | QC'd by SigmaAldrich | ||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -1.779 | 0 | -6.6502 | 0 | -1.779 | QC'd by SigmaAldrich | ||||||||||||||||||||||||||
| Cytotoxic | 5.6234 | 96.1911 | 84 | Complete curve; high efficacy | -5.25 | 4.9549 | 0.9999 | -95.6911 | 0.5 | -1.1 | 0 0 0 0 | -96.0754 | 0.1961 | 0 | -92.9298 | -96.0754 | QC'd by Specs | |||||||||||||||||||
| Cytotoxic | 5.6234 | 90.583 | 83 | Complete curve; high efficacy | -5.25 | 4.9549 | 0.9987 | -88.583 | 2 | -1.1 | 0 0 0 0 | -87.8799 | 0 | 3.2013 | -86.768 | -87.8799 | QC'd by Vitas | |||||||||||||||||||
| Cytotoxic | 0.7079 | 38.6161 | 66 | Complete curve; partial efficacy | -6.15 | 3.99 | 0.9995 | -74.868 | -36.2519 | -1.2 | 0 0 0 0 | -75.3228 | -41.8999 | -74.8595 | -74.5922 | -75.3228 | QC'd by Sequoia | |||||||||||||||||||
| Cytotoxic | 3.5481 | 102.2041 | 45 | Partial curve; high efficacy | -5.45 | 4.5045 | 0.9986 | -99.7041 | 2.5 | -2.1 | 0 0 0 0 | -99.5051 | 0 | 4.1801 | -25.022 | -99.5051 | QC'd by SIGMA | |||||||||||||||||||
| Cytotoxic | 8.9125 | 82.7294 | 43 | Partial curve; high efficacy | -5.05 | 1.5579 | 0.9999 | -91.2905 | -8.5611 | -2.1 | 0 0 0 0 | -87.443 | -9.2176 | -17.4332 | -57.2315 | -87.443 | QC'd by SigmaAldrich | |||||||||||||||||||
| Cytotoxic | 7.9433 | 95.3666 | 43 | Partial curve; high efficacy | -5.1 | 1.3443 | 0.9999 | -95.7901 | -0.4234 | -2.1 | 0 0 0 0 | -89.19 | -2.0195 | -15.8041 | -59.401 | -89.19 | QC'd by Bosche | |||||||||||||||||||
| Cytotoxic | 14.1254 | 99.6937 | 42 | Partial curve; high efficacy | -4.85 | 2.7202 | 0.9996 | -98.6937 | 1 | -2.1 | 0 0 0 0 | -96.7585 | 0 | 1.5165 | -34.3212 | -96.7585 | QC'd by NCI | |||||||||||||||||||
| Cytotoxic | 10 | 95.4536 | 42 | Partial curve; high efficacy | -5 | 3.9295 | 0.9998 | -96.4536 | -1 | -2.1 | 0 0 0 0 | -96.2611 | 0 | -1.9942 | -60.9288 | -96.2611 | QC'd by Microsource | |||||||||||||||||||
| Cytotoxic | 10 | 63.4673 | 42 | Partial curve; partial efficacy | -5 | 3.132 | 0.9999 | -62.9673 | 0.5 | -2.2 | 0 0 0 0 | -62.6906 | 0 | 0 | -37.6527 | -62.6906 | QC'd by APExBIO | |||||||||||||||||||
| Cytotoxic | 8.9125 | 71.9833 | 42 | Partial curve; partial efficacy | -5.05 | 4.095 | 1 | -71.9833 | 0 | -2.2 | 0 0 0 0 | -71.9151 | 0 | 0 | -52.954 | -71.9151 | QC'd by Sequoia | |||||||||||||||||||
| Cytotoxic | 14.1254 | 83.8763 | 41 | Partial curve; partial efficacy | -4.85 | 1.9282 | 0.9988 | -79.8763 | 4 | -2.2 | 0 0 0 0 | -74.8854 | 4.8403 | 0 | -28.1646 | -74.8854 | QC'd by Vitas | |||||||||||||||||||
| Cytotoxic | 22.3872 | 106.1577 | 41 | Partial curve; high efficacy | -4.65 | 2.2481 | 0.999 | -102.1577 | 4 | -2.1 | 0 0 0 0 | -90.5653 | 2.2185 | 4.8235 | -14.3188 | -90.5653 | QC'd by Microsource |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.0000080000 uM | Activity at 0.0000294000 uM | Activity at 0.0000322389 uM | Activity at 0.0000640000 uM | Activity at 0.0001602685 uM | Activity at 0.0003305803 uM | Activity at 0.0007029698 uM | Activity at 0.00145 uM | Activity at 0.00305 uM | Activity at 0.00484 uM | Activity at 0.00883 uM | Activity at 0.016 uM | Activity at 0.036 uM | Activity at 0.076 uM | Activity at 0.127 uM | Activity at 0.227 uM | Activity at 0.400 uM | Activity at 1.089 uM | Activity at 1.958 uM | Activity at 4.491 uM | Activity at 9.517 uM | Activity at 15.29 uM | Activity at 27.66 uM | Activity at 48.83 uM | Activity at 98.28 uM | Activity at 150.0 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inhibitor | 1.1535 | 84.011 | 86 | Complete curve; high efficacy | -5.938 | 2.9523 | 0.9935 | -85.511 | -1.5 | -1.1 | 0 0 0 0 0 0 1 | 0 | 0 | 0.5517 | 0 | -10.1942 | -66.3862 | -86.3747 | 0 | QC'd by MedChem Express | ||||||||||||||||||||
| Inhibitor | 4.0381 | 107.1309 | 85 | Complete curve; high efficacy | -5.3938 | 1.1 | 0.9833 | -107.6309 | -0.5 | -1.1 | 0 0 0 0 0 0 0 | -99.1076 | 3.0643 | -3.3561 | 2.7295 | -17.6643 | -28.702 | -81.8703 | -99.1076 | QC'd by Prestwick | ||||||||||||||||||||
| Inhibitor | 4.5309 | 100.6619 | 85 | Complete curve; high efficacy | -5.3438 | 1.4641 | 0.9928 | -111.2365 | -10.5746 | -1.1 | 0 0 0 0 0 0 0 | -102.4277 | -6.7289 | -14.1368 | -11.7774 | -11.5064 | -34.358 | -88.9997 | -102.4277 | QC'd by Glixx | ||||||||||||||||||||
| Inhibitor | 3.2076 | 94.9956 | 85 | Complete curve; high efficacy | -5.4938 | 1.6924 | 0.997 | -110.0264 | -15.0308 | -1.1 | 0 0 0 0 0 0 0 | -108.5073 | -10.859 | -15.7072 | -17.8113 | -19.7979 | -44.1871 | -99.3353 | -108.5073 | QC'd by MedChem Express | ||||||||||||||||||||
| Inhibitor | 3.2076 | 94.3335 | 85 | Complete curve; high efficacy | -5.4938 | 1.5579 | 0.9917 | -98.6297 | -4.2962 | -1.1 | 0 0 0 0 0 0 0 | -97.268 | -10.9671 | -0.2469 | -8.8219 | -8.6028 | -35.074 | -85.0291 | -97.268 | QC'd by Vitas | ||||||||||||||||||||
| Inhibitor | 4.0381 | 101.2244 | 85 | Complete curve; high efficacy | -5.3938 | 2.2481 | 0.9999 | -101.2244 | 0 | -1.1 | 0 0 0 0 0 0 0 | -101.0224 | 0 | 0 | 0.6663 | -1.57 | -17.0563 | -89.6716 | -101.0224 | QC'd by DC Chemicals | ||||||||||||||||||||
| Inhibitor | 4.5309 | 102.5293 | 84 | Complete curve; high efficacy | -5.3438 | 1.8851 | 0.9958 | -104.0293 | -1.5 | -1.1 | 0 0 0 0 0 0 0 | -100.8035 | 0 | 0 | -6.9667 | 0.0183 | -19.6985 | -87.3271 | -100.8035 | QC'd by MedChem Express | ||||||||||||||||||||
| Inhibitor | 5.1525 | 90.1537 | 84 | Complete curve; high efficacy | -5.288 | 1.9673 | 0.9895 | -98.5024 | -8.3487 | -1.1 | 0 0 0 0 0 0 0 | -96.571 | -12.4368 | -8.9031 | -14.8602 | -3.6239 | -19.2852 | -77.5914 | -96.571 | QC'd by EMD Chemicals | ||||||||||||||||||||
| Inhibitor | 6.4 | 96.4761 | 83 | Complete curve; high efficacy | -5.1938 | 3.9295 | 0.9988 | -94.9761 | 1.5 | -1.1 | 0 0 0 0 0 0 0 | -95.3575 | 0 | 3.3535 | 0 | 0 | 2.0026 | -79.8012 | -95.3575 | QC'd by Microsource | ||||||||||||||||||||
| Inhibitor | 6.4 | 89.099 | 83 | Complete curve; high efficacy | -5.1938 | 4.4495 | 0.9997 | -88.599 | 0.5 | -1.1 | 0 0 0 0 0 0 0 | -88.4222 | 0 | 0.504 | 2.2243 | 0 | 0 | -77.8921 | -88.4222 | QC'd by SigmaAldrich | ||||||||||||||||||||
| Inhibitor | 4.0928 | 572.5887 | 65 | Partial curve; high efficacy | -5.388 | 2.9023 | 1 | -572.5887 | 0 | -2.1 | 0 0 0 0 0 0 1 | 0 | 0 | 0 | 0 | 0 | -52.3008 | -521.4833 | 0 | QC'd by Microsource | ||||||||||||||||||||
| Inhibitor | 2.5479 | 77.6423 | 65 | Complete curve; partial efficacy | -5.5938 | 4.5045 | 0.9919 | -92.3162 | -14.6738 | -1.2 | 0 0 0 0 0 0 0 | -90.5524 | -12.7147 | -12.5699 | -11.8115 | -21.2763 | -34.6101 | -93.8172 | -90.5524 | QC'd by SIGMA | ||||||||||||||||||||
| Inhibitor | 2.0239 | 79.2033 | 65 | Complete curve; partial efficacy | -5.6938 | 1.111 | 0.9975 | -92.0986 | -12.8952 | -1.2 | 0 0 0 0 0 0 0 | -89.2428 | -13.3008 | -14.4831 | -11.996 | -25.7417 | -51.5286 | -82.1843 | -89.2428 | QC'd by SIGMA | ||||||||||||||||||||
| Inhibitor | 2.5479 | 39.7531 | 64 | Complete curve; partial efficacy | -5.5938 | 4.5045 | 0.9617 | -72.8813 | -33.1282 | -1.2 | 0 0 0 0 0 0 0 | -68.5285 | -37.2443 | -35.4912 | -31.4131 | -28.8568 | -43.7703 | -77.3346 | -68.5285 | QC'd by Microsource | ||||||||||||||||||||
| Inhibitor | 5.7812 | 259.63 | 50 | Partial curve; high efficacy | -5.238 | 1.6924 | 0.9999 | -259.63 | 0 | -2.1 | 0 0 0 0 0 0 0 | -250.1252 | 0 | 0 | 0 | -1.0316 | -34.0768 | -179.1962 | -250.1252 | QC'd by Adooq | ||||||||||||||||||||
| Inhibitor | 4.0928 | 222.4626 | 50 | Partial curve; high efficacy | -5.388 | 2.5884 | 0.9995 | -221.4626 | 1 | -2.1 | 0 0 0 0 0 0 1 | 0 | 0 | 0 | 0 | 3.8047 | -24.8352 | -196.3321 | 0 | QC'd by Glixx | ||||||||||||||||||||
| Inhibitor | 18.0377 | 742.5376 | 49 | Partial curve; high efficacy | -4.7438 | 2.7202 | 1 | -741.5376 | 1 | -2.1 | 0 0 0 0 0 0 0 | -698.2464 | 0 | 0 | 3.8335 | 0 | 0 | -124.2034 | -698.2464 | QC'd by Vitas | ||||||||||||||||||||
| Inhibitor | 16.0761 | 622.5036 | 49 | Partial curve; high efficacy | -4.7938 | 2.2526 | 1 | -622.5036 | 0 | -2.1 | 0 0 0 0 0 0 0 | -576.3922 | 0 | 0 | 0 | 0 | -5.8017 | -157.3588 | -576.3922 | QC'd by Glixx | ||||||||||||||||||||
| Inhibitor | 16.0761 | 415.8307 | 46 | Partial curve; high efficacy | -4.7938 | 2.2526 | 0.9995 | -418.3307 | -2.5 | -2.1 | 0 0 0 0 0 0 0 | -387.3433 | -6.0045 | 0 | 0 | -3.7575 | -3.0222 | -113.565 | -387.3433 | QC'd by SIGMA | ||||||||||||||||||||
| Inhibitor | 16.2936 | 426.1901 | 46 | Partial curve; high efficacy | -4.788 | 2.7202 | 0.9998 | -425.6901 | 0.5 | -2.1 | 0 0 0 0 0 0 0 | -400.8381 | 0 | 0 | 0 | 0 | 3.5739 | -74.4409 | -400.8381 | QC'd by MedChem Express |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.00457 uM | Activity at 0.023 uM | Activity at 0.046 uM | Activity at 0.104 uM | Activity at 0.151 uM | Activity at 0.229 uM | Activity at 0.457 uM | Activity at 0.573 uM | Activity at 0.907 uM | Activity at 1.145 uM | Activity at 2.290 uM | Activity at 3.065 uM | Activity at 5.336 uM | Activity at 6.860 uM | Activity at 11.40 uM | Activity at 15.33 uM | Activity at 26.44 uM | Activity at 34.30 uM | Activity at 57.10 uM | Activity at 85.70 uM | Activity at 114.5 uM | Activity at 171.0 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inhibitor | 1 | 96.3339 | 87 | Complete curve; high efficacy | -6 | 4.9549 | 0.9998 | -94.3339 | 2 | -1.1 | 0 0 0 0 | -94.7128 | 0 | -92.7751 | -93.4163 | -94.7128 | QC'd by Labotest | |||||||||||||||||||
| Inhibitor | 0.8913 | 83.7126 | 87 | Complete curve; high efficacy | -6.05 | 2.7868 | 0.9996 | -96.241 | -12.5283 | -1.1 | 0 0 0 0 | -96.6275 | -23.7736 | -90.8469 | -95.0049 | -96.6275 | QC'd by Microsource | |||||||||||||||||||
| Inhibitor | 1.2589 | 96.4059 | 87 | Complete curve; high efficacy | -5.9 | 3.6772 | 0.9999 | -94.4059 | 2 | -1.1 | 0 0 0 0 | -94.785 | 0 | -85.1427 | -94.1736 | -94.785 | QC'd by MedChem Express | |||||||||||||||||||
| Inhibitor | 1.9953 | 95.4473 | 86 | Complete curve; high efficacy | -5.7 | 3.132 | 1 | -95.4473 | 0 | -1.1 | 0 0 0 0 | -95.2568 | 0 | -13.739 | -92.0399 | -95.2568 | QC'd by Vitas | |||||||||||||||||||
| Inhibitor | 3.5481 | 97.4639 | 85 | Complete curve; high efficacy | -5.45 | 4.095 | 0.9999 | -96.9639 | 0.5 | -1.1 | 0 0 0 0 | -96.7703 | 0 | -13.1147 | -96.7363 | -96.7703 | QC'd by Vitas | |||||||||||||||||||
| Inhibitor | 2.5119 | 83.5277 | 85 | Complete curve; high efficacy | -5.6 | 2.0479 | 0.9986 | -97.9692 | -14.4414 | -1.1 | 0 0 0 0 | -97.1916 | -15.3679 | -54.1106 | -93.8954 | -97.1916 | QC'd by Selleck | |||||||||||||||||||
| Inhibitor | 3.5481 | 95.2164 | 85 | Complete curve; high efficacy | -5.45 | 1.3443 | 0.9998 | -100.6043 | -5.3878 | -1.1 | 0 0 0 0 | -99.2152 | -11.1565 | -39.2196 | -83.7948 | -99.2152 | QC'd by Microsource | |||||||||||||||||||
| Inhibitor | 5.6234 | 95.3043 | 84 | Complete curve; high efficacy | -5.25 | 4.9549 | 0.9998 | -94.8043 | 0.5 | -1.1 | 0 0 0 0 | -94.0519 | 0.1207 | 0 | -92.6695 | -94.0519 | QC'd by NCI | |||||||||||||||||||
| Inhibitor | 4.4668 | 84.5044 | 84 | Complete curve; high efficacy | -5.35 | 1.2876 | 0.9998 | -86.2923 | -1.788 | -1.1 | 0 0 0 0 | -82.6781 | -5.6567 | -27.5762 | -66.8514 | -82.6781 | QC'd by Microsource | |||||||||||||||||||
| Inhibitor | 5.6234 | 94.3082 | 84 | Complete curve; high efficacy | -5.25 | 4.9549 | 0.9999 | -93.8082 | 0.5 | -1.1 | 0 0 0 0 | -93.6209 | 0 | 0 | -91.0139 | -93.6209 | QC'd by Microsource | |||||||||||||||||||
| Inhibitor | 5.0119 | 95.7879 | 84 | Complete curve; high efficacy | -5.3 | 4.9549 | 0.9998 | -94.7879 | 1 | -1.1 | 0 0 0 0 | -94.5987 | 0 | 0 | -93.6402 | -94.5987 | QC'd by Microsource | |||||||||||||||||||
| Inhibitor | 7.0795 | 97.8501 | 83 | Complete curve; high efficacy | -5.15 | 4.5045 | 0.9989 | -95.8501 | 2 | -1.1 | 0 0 0 0 | -96.235 | 0 | 3.6521 | -85.6349 | -96.235 | QC'd by SigmaAldrich | |||||||||||||||||||
| Inhibitor | 7.0795 | 100.267 | 83 | Complete curve; high efficacy | -5.15 | 4.9549 | 0.9991 | -98.767 | 1.5 | -1.1 | 0 0 0 0 | -97.9831 | 0 | 3.2082 | -91.1572 | -97.9831 | QC'd by Vitas | |||||||||||||||||||
| Inhibitor | 8.9125 | 93.9061 | 83 | Complete curve; high efficacy | -5.05 | 4.9549 | 0.9997 | -93.9061 | 0 | -1.1 | 0 0 0 0 | -93.1608 | 0 | 0 | -73.8376 | -93.1608 | QC'd by Prestwick | |||||||||||||||||||
| Inhibitor | 7.9433 | 89.6297 | 83 | Complete curve; high efficacy | -5.1 | 4.5045 | 1 | -89.6297 | 0 | -1.1 | 0 0 0 0 | -89.4508 | 0 | 0 | -75.1088 | -89.4508 | QC'd by Microsource | |||||||||||||||||||
| Inhibitor | 0.7943 | 67.8185 | 68 | Complete curve; partial efficacy | -6.1 | 1.6259 | 0.9992 | -98.2669 | -30.4484 | -1.2 | 0 0 0 0 | -98.6616 | -49.9386 | -88.086 | -96.3968 | -98.6616 | QC'd by Selleck | |||||||||||||||||||
| Inhibitor | 0.8913 | 67.0637 | 67 | Complete curve; partial efficacy | -6.05 | 3.5117 | 0.9999 | -94.9798 | -27.9161 | -1.2 | 0 0 0 0 | -95.3612 | -33.7668 | -92.536 | -94.9745 | -95.3612 | QC'd by SIGMA | |||||||||||||||||||
| Inhibitor | 0.8913 | 74.0588 | 67 | Complete curve; partial efficacy | -6.05 | 2.7868 | 0.9997 | -93.5396 | -19.4808 | -1.2 | 0 0 0 0 | -94.4845 | -29.5673 | -88.416 | -93.2736 | -94.4845 | QC'd by MedChem Express | |||||||||||||||||||
| Inhibitor | 2.8184 | 72.5884 | 65 | Complete curve; partial efficacy | -5.55 | 2.4064 | 0.9994 | -99.8255 | -27.2371 | -1.2 | 0 0 0 0 | -99.0333 | -28.5309 | -54.1516 | -98.53 | -99.0333 | QC'd by GVK | |||||||||||||||||||
| Inhibitor | 3.5481 | 47.2717 | 65 | Complete curve; partial efficacy | -5.45 | 2.1211 | 0.9998 | -98.6785 | -51.4068 | -1.2 | 0 0 0 0 | -98.4816 | -51.7655 | -65.2319 | -95.3281 | -98.4816 | QC'd by Microsource |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.00457 uM | Activity at 0.00705 uM | Activity at 0.023 uM | Activity at 0.046 uM | Activity at 0.070 uM | Activity at 0.104 uM | Activity at 0.147 uM | Activity at 0.228 uM | Activity at 0.454 uM | Activity at 0.702 uM | Activity at 0.990 uM | Activity at 1.179 uM | Activity at 2.205 uM | Activity at 3.547 uM | Activity at 5.245 uM | Activity at 6.528 uM | Activity at 11.35 uM | Activity at 18.98 uM | Activity at 27.12 uM | Activity at 37.89 uM | Activity at 57.10 uM | Activity at 85.70 uM | Activity at 114.4 uM | Activity at 171.0 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cytotoxic | 2.5119 | 89.963 | 85 | Complete curve; high efficacy | -5.6 | 2.4064 | 0.9988 | -81.963 | 8 | -1.1 | 0 0 0 0 | -81.0256 | 4.3424 | -26.1944 | -82.8623 | -81.0256 | QC'd by MedChem Express | |||||||||||||||||||||
| Cytotoxic | 3.1623 | 94.5377 | 85 | Complete curve; high efficacy | -5.5 | 4.5045 | 0.9999 | -94.3225 | 0.2153 | -1.1 | 0 0 0 0 | -94.7013 | -0.2373 | -13.1526 | -93.6408 | -94.7013 | QC'd by SIGMA | |||||||||||||||||||||
| Cytotoxic | 2.8184 | 94.817 | 85 | Complete curve; high efficacy | -5.55 | 2.0479 | 0.9999 | -95.8221 | -1.005 | -1.1 | 0 0 0 0 | -95.0616 | -6.2542 | -35.3146 | -94.5292 | -95.0616 | QC'd by APExBIO | |||||||||||||||||||||
| Cytotoxic | 2.8184 | 90.5207 | 85 | Complete curve; high efficacy | -5.55 | 3.0654 | 0.9989 | -88.5207 | 2 | -1.1 | 0 0 0 0 | -86.8835 | 0 | -24.056 | -89.9601 | -86.8835 | QC'd by MedChem Express | |||||||||||||||||||||
| Cytotoxic | 5.6234 | 96.9742 | 84 | Complete curve; high efficacy | -5.25 | 4.095 | 1 | -95.4742 | 1.5 | -1.1 | 0 0 0 0 | -95.8576 | 1.6559 | 0 | -94.7507 | -95.8576 | QC'd by SynKinase | |||||||||||||||||||||
| Cytotoxic | 3.9811 | 96.1006 | 84 | Complete curve; high efficacy | -5.4 | 4.5045 | 1 | -95.1006 | 1 | -1.1 | 0 0 0 0 | -94.9108 | 0.5692 | -4.2795 | -94.8159 | -94.9108 | QC'd by Tocris | |||||||||||||||||||||
| Cytotoxic | 2.5119 | 77.6563 | 84 | Complete curve; high efficacy | -5.6 | 2.0479 | 0.9997 | -80.7421 | -3.0858 | -1.1 | 0 0 0 0 | -80.0369 | -5.0715 | -39.0219 | -77.613 | -80.0369 | QC'd by Microsource | |||||||||||||||||||||
| Cytotoxic | 7.9433 | 99.4986 | 83 | Complete curve; high efficacy | -5.1 | 4.9549 | 0.9997 | -96.9986 | 2.5 | -1.1 | 0 0 0 0 | -96.805 | 1.2306 | 3.5418 | -95.9316 | -96.805 | QC'd by MedChem Express | |||||||||||||||||||||
| Cytotoxic | 7.0795 | 97.8358 | 83 | Complete curve; high efficacy | -5.15 | 4.9549 | 0.9993 | -95.8358 | 2 | -1.1 | 0 0 0 0 | -95.6445 | 0 | 3.4249 | -95.1788 | -95.6445 | QC'd by Tocris | |||||||||||||||||||||
| Cytotoxic | 7.0795 | 97.3751 | 83 | Complete curve; high efficacy | -5.15 | 4.095 | 1 | -97.3751 | 0 | -1.1 | 0 0 0 0 | -97.1807 | 0 | -0.6843 | -95.5282 | -97.1807 | QC'd by MedChem Express | |||||||||||||||||||||
| Cytotoxic | 7.0795 | 102.4399 | 83 | Complete curve; high efficacy | -5.15 | 1.6924 | 0.9998 | -100.4399 | 2 | -1.1 | 0 0 0 0 | -96.7629 | 0 | -9.8984 | -85.0051 | -96.7629 | QC'd by MedChem Express | |||||||||||||||||||||
| Cytotoxic | 7.0795 | 96.3568 | 83 | Complete curve; high efficacy | -5.15 | 4.9549 | 1 | -96.3568 | 0 | -1.1 | 0 0 0 0 | -96.1644 | 0 | 0 | -95.5939 | -96.1644 | QC'd by MedChem Express | |||||||||||||||||||||
| Cytotoxic | 7.0795 | 93.6127 | 83 | Complete curve; high efficacy | -5.15 | 4.9549 | 1 | -93.6127 | 0 | -1.1 | 0 0 0 0 | -93.4258 | 0 | 0 | -92.8807 | -93.4258 | QC'd by MedChem Express | |||||||||||||||||||||
| Cytotoxic | 8.9125 | 97.1357 | 83 | Complete curve; high efficacy | -5.05 | 4.9549 | 1 | -97.1357 | 0 | -1.1 | 0 0 0 0 | -96.9418 | 0 | 0 | -94.9322 | -96.9418 | QC'd by APExBIO | |||||||||||||||||||||
| Cytotoxic | 8.9125 | 105.034 | 83 | Complete curve; high efficacy | -5.05 | 1.6436 | 0.9999 | -100.034 | 5 | -1.1 | 0 0 0 0 | -94.7292 | 3.0536 | -3.9173 | -76.9038 | -94.7292 | QC'd by Glixx | |||||||||||||||||||||
| Cytotoxic | 10 | 91.3037 | 82 | Complete curve; high efficacy | -5 | 2.1876 | 1 | -85.8037 | 5.5 | -1.1 | 0 0 0 0 | -84.1212 | 4.8646 | 2.5388 | -67.7158 | -84.1212 | QC'd by SIGMA | |||||||||||||||||||||
| Cytotoxic | 10 | 98.1252 | 82 | Complete curve; high efficacy | -5 | 2.8473 | 0.9999 | -97.6252 | 0.5 | -1.1 | 0 0 0 0 | -96.8504 | 0 | 0 | -83.9555 | -96.8504 | QC'd by Cayman | |||||||||||||||||||||
| Cytotoxic | 11.2202 | 93.8772 | 82 | Complete curve; high efficacy | -4.95 | 2.4064 | 0.9998 | -92.8772 | 1 | -1.1 | 0 0 0 0 | -91.0561 | 0 | 0 | -72.1776 | -91.0561 | QC'd by Selleck | |||||||||||||||||||||
| Cytotoxic | 0.8913 | 60.2348 | 67 | Complete curve; partial efficacy | -6.05 | 3.5117 | 0.9985 | -93.1767 | -32.9418 | -1.2 | 0 0 0 0 | -93.5509 | -51.1212 | -90.8041 | -91.9137 | -93.5509 | QC'd by Selleck | |||||||||||||||||||||
| Cytotoxic | 0.7943 | 56.6802 | 67 | Complete curve; partial efficacy | -6.1 | 3.9295 | 0.9999 | -91.2497 | -34.5695 | -1.2 | 0 0 0 0 | -91.0675 | -40.2642 | -90.3425 | -90.8279 | -91.0675 | QC'd by MedChem Express |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.00457 uM | Activity at 0.023 uM | Activity at 0.046 uM | Activity at 0.104 uM | Activity at 0.151 uM | Activity at 0.229 uM | Activity at 0.457 uM | Activity at 0.573 uM | Activity at 0.907 uM | Activity at 1.145 uM | Activity at 2.290 uM | Activity at 3.065 uM | Activity at 5.336 uM | Activity at 6.860 uM | Activity at 11.40 uM | Activity at 15.33 uM | Activity at 26.44 uM | Activity at 34.30 uM | Activity at 57.10 uM | Activity at 85.70 uM | Activity at 114.5 uM | Activity at 171.0 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cytotoxic | 3.1623 | 91.436 | 85 | Complete curve; high efficacy | -5.5 | 3.9295 | 0.9999 | -96.4465 | -5.0105 | -1.1 | 0 0 0 0 | -96.1361 | -4.5921 | -25.7892 | -96.254 | -96.1361 | QC'd by Labotest | |||||||||||||||||||
| Cytotoxic | 3.9811 | 95.7517 | 84 | Complete curve; high efficacy | -5.4 | 4.5045 | 0.9999 | -95.7517 | 0 | -1.1 | 0 0 0 0 | -95.1932 | 0 | -7.5797 | -95.5606 | -95.1932 | QC'd by Microsource | |||||||||||||||||||
| Cytotoxic | 1.2589 | 40.7314 | 66 | Complete curve; partial efficacy | -5.9 | 1.21 | 0.9997 | -86.599 | -45.8676 | -1.2 | 0 0 0 0 | -85.9117 | -55.1995 | -73.2026 | -84.1817 | -85.9117 | QC'd by Enzo | |||||||||||||||||||
| Cytotoxic | 8.9125 | 98.067 | 43 | Partial curve; high efficacy | -5.05 | 3.0654 | 0.9999 | -97.567 | 0.5 | -2.1 | 0 0 0 0 | -95.0946 | 0 | 0.6077 | -19.7721 | -95.0946 | QC'd by Tocris | |||||||||||||||||||
| Cytotoxic | 10 | 105.2449 | 42 | Partial curve; high efficacy | -5 | 1.1341 | 0.9999 | -99.7449 | 5.5 | -2.1 | 0 0 0 0 | -87.0375 | 1.9925 | -11.2908 | -50.5231 | -87.0375 | QC'd by SigmaAldrich | |||||||||||||||||||
| Cytotoxic | 7.0795 | 74.1897 | 42 | Partial curve; partial efficacy | -5.15 | 1.21 | 0.9998 | -75.7999 | -1.6102 | -2.2 | 0 0 0 0 | -69.9242 | -3.8419 | -17.0574 | -49.2901 | -69.9242 | QC'd by Sequoia | |||||||||||||||||||
| Cytotoxic | 10 | 82.2501 | 42 | Partial curve; high efficacy | -5 | 2.7868 | 0.9996 | -81.2501 | 1 | -2.1 | 0 0 0 0 | -80.9212 | 0 | 0 | -46.8123 | -80.9212 | QC'd by Bosche | |||||||||||||||||||
| Cytotoxic | 11.2202 | 70.7514 | 42 | Partial curve; partial efficacy | -4.95 | 3.132 | 0.9997 | -70.7514 | 0 | -2.2 | 0 0 0 0 | -69.6773 | 0 | 0 | -36.9652 | -69.6773 | QC'd by Vitas | |||||||||||||||||||
| Cytotoxic | 11.2202 | 67.551 | 42 | Partial curve; partial efficacy | -4.95 | 2.4064 | 0.9997 | -67.551 | 0 | -2.2 | 0 0 0 0 | -65.8342 | 0 | -1.4108 | -35.2917 | -65.8342 | QC'd by Sequoia | |||||||||||||||||||
| Cytotoxic | 7.9433 | 73.0806 | 42 | Partial curve; partial efficacy | -5.1 | 1.2221 | 0.9998 | -71.0806 | 2 | -2.2 | 0 0 0 0 | -64.7465 | 0 | -11.4632 | -42.9379 | -64.7465 | QC'd by Microsource | |||||||||||||||||||
| Cytotoxic | 22.3872 | 77.7774 | 41 | Partial curve; partial efficacy | -4.65 | 2.1211 | 1 | -77.7774 | 0 | -2.2 | 0 0 0 0 | -68.392 | 0 | -0.4599 | -15.1027 | -68.392 | QC'd by Enzo | |||||||||||||||||||
| Cytotoxic | 12.5893 | 69.0258 | 41 | Partial curve; partial efficacy | -4.9 | 1.9887 | 0.9999 | -66.0258 | 3 | -2.2 | 0 0 0 0 | -62.9869 | 2.8182 | 0.7552 | -27.7994 | -62.9869 | QC'd by Microsource | |||||||||||||||||||
| Cytotoxic | 19.9526 | 72.7716 | 41 | Partial curve; partial efficacy | -4.7 | 2.0479 | 0.9998 | -72.2716 | 0.5 | -2.2 | 0 0 0 0 | -64.5997 | 0 | 0 | -16.6801 | -64.5997 | QC'd by Prestwick | |||||||||||||||||||
| Cytotoxic | 28.1838 | 115.9951 | 40 | Partial curve; high efficacy | -4.55 | 2.2481 | 0.9999 | -115.4951 | 0.5 | -2.1 | 0 0 0 0 | -95.7671 | 0 | 0 | -12.122 | -95.7671 | QC'd by Sequoia | |||||||||||||||||||
| Cytotoxic | 31.6228 | 66.0212 | 40 | Partial curve; partial efficacy | -4.5 | 4.9549 | 0.9998 | -66.0212 | 0 | -2.2 | 0 0 0 0 | -65.8081 | 0 | 0 | -10.4112 | -65.8081 | QC'd by AKos | |||||||||||||||||||
| Cytotoxic | 28.1838 | 106.7654 | 40 | Partial curve; high efficacy | -4.55 | 2.2481 | 1 | -106.7654 | 0 | -2.1 | 0 0 0 0 | -88.5285 | 0 | 0 | -12.0122 | -88.5285 | QC'd by Toronto Research | |||||||||||||||||||
| Cytotoxic | 31.6228 | 126.8203 | 40 | Partial curve; high efficacy | -4.5 | 2.0437 | 1 | -126.3203 | 0.5 | -2.1 | 0 0 0 0 | -97.0202 | 0.5949 | 0 | -13.8992 | -97.0202 | QC'd by Selleck | |||||||||||||||||||
| Cytotoxic | 2.5119 | 46.5563 | 23 | Complete curve; partial efficacy | -5.6 | 1.1341 | 0.9987 | -46.4031 | 0.1532 | -1.2 | 0 0 0 0 | -45.0904 | -4.8723 | -22.5413 | -38.9308 | -45.0904 | QC'd by Sequoia | |||||||||||||||||||
| Cytotoxic | 2.2387 | 43.9543 | 23 | Complete curve; partial efficacy | -5.65 | 1.4163 | 0.9994 | -48.3722 | -4.4179 | -1.2 | 0 0 0 0 | -48.5721 | -8.6816 | -27.0016 | -44.0154 | -48.5721 | QC'd by Vitas | |||||||||||||||||||
| Cytotoxic | 1.2589 | 51.9326 | 23 | Complete curve; partial efficacy | -5.9 | 2.6384 | 0.9993 | -48.4326 | 3.5 | -1.2 | 0 0 0 0 | -49.0117 | 0 | -39.4678 | -47.3958 | -49.0117 | QC'd by MedChem Express |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.00457 uM | Activity at 0.00705 uM | Activity at 0.023 uM | Activity at 0.046 uM | Activity at 0.070 uM | Activity at 0.104 uM | Activity at 0.147 uM | Activity at 0.228 uM | Activity at 0.454 uM | Activity at 0.702 uM | Activity at 0.990 uM | Activity at 1.179 uM | Activity at 2.205 uM | Activity at 3.547 uM | Activity at 5.245 uM | Activity at 6.528 uM | Activity at 11.35 uM | Activity at 18.98 uM | Activity at 27.12 uM | Activity at 37.89 uM | Activity at 57.10 uM | Activity at 85.70 uM | Activity at 114.4 uM | Activity at 171.0 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inhibitor | 0.7079 | 34.8288 | 10 | Complete curve; partial efficacy; poor fit | -6.15 | 4.9549 | 0.7525 | -34.8113 | 0.0174 | -1.4 | 0 0 0 0 | -43.6793 | -3.7355 | -37.8905 | -22.6342 | -43.6793 | QC'd by MedChem Express | |||||||||||||||||||||
| Inhibitor | 35.4813 | 36.7648 | 10 | Single point of activity | -4.45 | 2.4064 | 0.8748 | -40.7648 | -4 | -3 | 0 0 0 0 | -31.8873 | -11.4596 | 0 | -6.0521 | -31.8873 | QC'd by Pharmaron | |||||||||||||||||||||
| Inhibitor | 39.8107 | 40.3927 | 10 | Single point of activity | -4.4 | 4.4495 | 0.7948 | -48.5731 | -8.1804 | -3 | 0 0 0 0 | -41.7275 | -5.1127 | -20.8986 | -3.4837 | -41.7275 | QC'd by FLUKA | |||||||||||||||||||||
| Inhibitor | 39.8107 | 36.3021 | 10 | Single point of activity | -4.4 | 4.4495 | 0.9302 | -39.3021 | -3 | -3 | 0 0 0 0 | -33.1684 | -8.7659 | 0 | -0.1246 | -33.1684 | QC'd by Prestwick | |||||||||||||||||||||
| Inhibitor | 10 | 91.8254 | 10 | Partial curve; high efficacy; poor fit | -5 | 3.9295 | 1 | -91.3254 | 0.5 | -2.3 | 1 0 0 0 | -91.1431 | -30.038 | 0 | -57.0259 | -91.1431 | QC'd by APExBIO | |||||||||||||||||||||
| Inhibitor | 39.8107 | 88.8726 | 10 | Single point of activity | -4.4 | 4.9549 | 0.9981 | -87.8726 | 1 | -3 | 0 0 0 0 | -75.3105 | 0 | 0 | 3.3645 | -75.3105 | QC'd by Microsource | |||||||||||||||||||||
| Inhibitor | 39.8107 | 39.074 | 10 | Single point of activity | -4.4 | 4.9549 | 0.9982 | -38.574 | 0.5 | -3 | 0 0 0 0 | -32.9783 | 0 | 0 | 1.4313 | -32.9783 | QC'd by Carbosynth | |||||||||||||||||||||
| Inhibitor | 17.7828 | 45.6593 | 10 | Partial curve; partial efficacy; poor fit | -4.75 | 1.9673 | 0.9887 | -54.3257 | -8.6664 | -2.4 | 0 0 0 0 | -50.2467 | -11.0836 | -6.8054 | -21.6158 | -50.2467 | QC'd by TargetMol | |||||||||||||||||||||
| Inhibitor | 39.8107 | 74.9786 | 10 | Single point of activity | -4.4 | 4.4495 | 0.9815 | -77.9786 | -3 | -3 | 0 0 0 0 | -65.3989 | -8.9317 | 0 | 0 | -65.3989 | QC'd by MedChem Express | |||||||||||||||||||||
| Inhibitor | 39.8107 | 35.788 | 10 | Single point of activity | -4.4 | 4.4495 | 0.945 | -39.8408 | -4.0529 | -3 | 0 0 0 0 | -34.034 | -8.1712 | -5.8755 | -0.0441 | -34.034 | QC'd by Adooq | |||||||||||||||||||||
| Inhibitor | 19.9526 | 98.5475 | 10 | Partial curve; high efficacy; poor fit | -4.7 | 1.9673 | 0.9936 | -101.5475 | -3 | -2.3 | 0 0 0 0 | -90.5058 | -6.6702 | 0 | -28.4282 | -90.5058 | QC'd by MedChem Express | |||||||||||||||||||||
| Inhibitor | 39.8107 | 94.2096 | 10 | Partial curve; high efficacy; poor fit | -4.4 | 4.4495 | 0.9731 | -106.3898 | -12.1802 | -2.3 | 0 0 0 0 | -90.4675 | -6.8168 | -21.693 | -10.2877 | -90.4675 | QC'd by Axon Medchem | |||||||||||||||||||||
| Inhibitor | 39.8107 | 68.3394 | 10 | Single point of activity | -4.4 | 4.9549 | 0.8933 | -61.3394 | 7 | -3 | 0 0 0 0 | -51.5329 | 0 | 0 | 21.3412 | -51.5329 | QC'd by MedChem Express | |||||||||||||||||||||
| Inhibitor | 11.2202 | 45.0575 | 10 | Partial curve; partial efficacy; poor fit | -4.95 | 1.8579 | 0.9996 | -42.5575 | 2.5 | -2.4 | 1 0 0 0 | -40.794 | -21.6798 | 0 | -20.0057 | -40.794 | QC'd by MedChem Express | |||||||||||||||||||||
| Inhibitor | 22.3872 | 113.3323 | 10 | Partial curve; high efficacy; poor fit | -4.65 | 1.6924 | 1 | -111.3323 | 2 | -2.3 | 1 0 0 0 | -91.8583 | -33.8793 | 0 | -25.3979 | -91.8583 | QC'd by Microsource | |||||||||||||||||||||
| Inhibitor | 7.0795 | 44.42 | 10 | Single point of activity | -5.15 | 4.9549 | 0.6152 | -48.42 | -4 | -3 | 0 0 0 0 | -44.8333 | -14.7954 | -20.376 | 0 | -44.8333 | QC'd by SIGMA | |||||||||||||||||||||
| Inhibitor | 39.8107 | 32.9185 | 10 | Single point of activity | -4.4 | 4.9549 | 0.6127 | -36.9185 | -4 | -3 | 0 0 0 0 | -32.0154 | 2.7163 | -20.0828 | 0 | -32.0154 | QC'd by Selleck | |||||||||||||||||||||
| Inhibitor | 39.8107 | 51.1844 | 10 | Single point of activity | -4.4 | 4.4495 | 1 | -51.1844 | 0 | -3 | 0 0 0 0 | -42.6537 | 0 | 0 | 0 | -42.6537 | QC'd by MedChem Express | |||||||||||||||||||||
| Inhibitor | 10 | 58.1799 | 10 | Partial curve; partial efficacy; poor fit | -5 | 3.5117 | 0.9887 | -59.1799 | -1 | -2.4 | 0 0 0 0 | -59.8069 | -4.8747 | 2.0564 | -35.7833 | -59.8069 | QC'd by DC Chemicals | |||||||||||||||||||||
| Inhibitor | 39.8107 | 40.2901 | 10 | Single point of activity | -4.4 | 4.4495 | 0.7334 | -45.6865 | -5.3964 | -3 | 0 0 0 0 | -38.9054 | -16.4277 | -13.0282 | -1.1636 | -38.9054 | QC'd by Adooq |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.00457 uM | Activity at 0.023 uM | Activity at 0.046 uM | Activity at 0.104 uM | Activity at 0.151 uM | Activity at 0.229 uM | Activity at 0.457 uM | Activity at 0.573 uM | Activity at 0.907 uM | Activity at 1.145 uM | Activity at 2.290 uM | Activity at 3.065 uM | Activity at 5.336 uM | Activity at 6.860 uM | Activity at 11.40 uM | Activity at 15.33 uM | Activity at 26.44 uM | Activity at 34.30 uM | Activity at 57.10 uM | Activity at 85.70 uM | Activity at 114.5 uM | Activity at 171.0 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inhibitor | 1 | 97.3802 | 87 | Complete curve; high efficacy | -6 | 1.3723 | 0.9991 | -99.9438 | -2.5636 | -1.1 | 0 0 0 0 | -99.1506 | -27.553 | -75.0674 | -97.7163 | -99.1506 | QC'd by Microsource | |||||||||||||||||||
| Inhibitor | 1.4125 | 98.8884 | 87 | Complete curve; high efficacy | -5.85 | 3.2475 | 0.9999 | -96.3884 | 2.5 | -1.1 | 0 0 0 0 | -96.7755 | 0 | -80.0472 | -95.8934 | -96.7755 | QC'd by Labotest | |||||||||||||||||||
| Inhibitor | 1.4125 | 101.0752 | 87 | Complete curve; high efficacy | -5.85 | 4.4495 | 0.9999 | -97.5752 | 3.5 | -1.1 | 0 0 0 0 | -97.9671 | 2.8759 | -86.7011 | -96.8007 | -97.9671 | QC'd by Labotest | |||||||||||||||||||
| Inhibitor | 1 | 102.2463 | 87 | Complete curve; high efficacy | -6 | 4.095 | 0.9999 | -98.2463 | 4 | -1.1 | 0 0 0 0 | -98.6409 | 0 | -94.9201 | -97.3825 | -98.6409 | QC'd by Selleck | |||||||||||||||||||
| Inhibitor | 1 | 100.876 | 87 | Complete curve; high efficacy | -6 | 2.0437 | 0.9997 | -97.5823 | 3.2937 | -1.1 | 0 0 0 0 | -97.9742 | -13.5052 | -82.6458 | -96.1026 | -97.9742 | QC'd by Microsource | |||||||||||||||||||
| Inhibitor | 2.2387 | 93.9081 | 86 | Complete curve; high efficacy | -5.65 | 1.9673 | 0.9988 | -99.4111 | -5.503 | -1.1 | 0 0 0 0 | -98.0385 | -9.5858 | -51.8655 | -97.2234 | -98.0385 | QC'd by SIGMA | |||||||||||||||||||
| Inhibitor | 2.8184 | 97.8218 | 85 | Complete curve; high efficacy | -5.55 | 2.7202 | 0.9992 | -96.8218 | 1 | -1.1 | 0 0 0 0 | -95.7136 | 0 | -33.6037 | -96.6286 | -95.7136 | QC'd by NCI | |||||||||||||||||||
| Inhibitor | 3.1623 | 82.2738 | 85 | Complete curve; high efficacy | -5.5 | 2.8473 | 0.9999 | -99.8849 | -17.6111 | -1.1 | 0 0 0 0 | -99.6855 | -18.0092 | -40.9738 | -98.4052 | -99.6855 | QC'd by Vitas | |||||||||||||||||||
| Inhibitor | 3.5481 | 88.7646 | 85 | Complete curve; high efficacy | -5.45 | 2.9523 | 0.9987 | -97.5643 | -8.7996 | -1.1 | 0 0 0 0 | -99.1507 | -8.1663 | -29.4656 | -93.2495 | -99.1507 | QC'd by Glixx | |||||||||||||||||||
| Inhibitor | 3.1623 | 99.7864 | 85 | Complete curve; high efficacy | -5.5 | 2.4729 | 0.9993 | -99.7864 | 0 | -1.1 | 0 0 0 0 | -98.4086 | 0 | -32.3549 | -96.4346 | -98.4086 | QC'd by MedChem Express | |||||||||||||||||||
| Inhibitor | 3.5481 | 91.7419 | 84 | Complete curve; high efficacy | -5.45 | 2.3531 | 0.9997 | -93.2919 | -1.55 | -1.1 | 0 0 0 0 | -93.6666 | -1.7084 | -26.6215 | -87.3985 | -93.6666 | QC'd by SIGMA | |||||||||||||||||||
| Inhibitor | 5.6234 | 98.8378 | 84 | Complete curve; high efficacy | -5.25 | 4.9549 | 1 | -98.8378 | 0 | -1.1 | 0 0 0 0 | -98.6405 | 0 | -1.6294 | -96.1264 | -98.6405 | QC'd by Microsource | |||||||||||||||||||
| Inhibitor | 3.9811 | 97.1295 | 84 | Complete curve; high efficacy | -5.4 | 4.5045 | 1 | -97.1295 | 0 | -1.1 | 0 0 0 0 | -97.5196 | 0 | -7.4315 | -96.036 | -97.5196 | QC'd by Microsource | |||||||||||||||||||
| Inhibitor | 0.8913 | 74.1887 | 68 | Complete curve; partial efficacy | -6.05 | 3.1925 | 0.9999 | -97.3803 | -23.1916 | -1.2 | 0 0 0 0 | -97.7714 | -30.993 | -94.0197 | -96.8652 | -97.7714 | QC'd by ChemDiv | |||||||||||||||||||
| Inhibitor | 0.7943 | 77.9517 | 68 | Complete curve; partial efficacy | -6.1 | 4.4495 | 0.9989 | -96.4651 | -18.5134 | -1.2 | 0 0 0 0 | -96.8525 | -24.5945 | -96.6992 | -94.6899 | -96.8525 | QC'd by SIGMA | |||||||||||||||||||
| Inhibitor | 0.8913 | 62.3816 | 68 | Complete curve; partial efficacy | -6.05 | 3.132 | 0.9999 | -97.0294 | -34.6478 | -1.2 | 0 0 0 0 | -97.4191 | -41.2998 | -94.2087 | -97.0954 | -97.4191 | QC'd by MedChem Express | |||||||||||||||||||
| Inhibitor | 3.1623 | 64.8408 | 65 | Complete curve; partial efficacy | -5.5 | 3.2475 | 0.9993 | -96.5147 | -31.6739 | -1.2 | 0 0 0 0 | -95.2478 | -31.8116 | -48.6639 | -96.3221 | -95.2478 | QC'd by Prestwick | |||||||||||||||||||
| Inhibitor | 8.9125 | 96.797 | 43 | Partial curve; high efficacy | -5.05 | 4.095 | 0.9999 | -96.797 | 0 | -2.1 | 0 0 0 0 | -97.1858 | 0 | 0 | -70.4182 | -97.1858 | QC'd by Sequoia | |||||||||||||||||||
| Inhibitor | 12.5893 | 99.3085 | 42 | Partial curve; high efficacy | -4.9 | 2.4064 | 0.9995 | -98.3085 | 1 | -2.1 | 0 0 0 0 | -96.3809 | 0 | 0 | -41.6052 | -96.3809 | QC'd by Tocris | |||||||||||||||||||
| Inhibitor | 14.1254 | 93.0173 | 42 | Partial curve; high efficacy | -4.85 | 1.6924 | 0.9985 | -94.0173 | -1 | -2.1 | 0 0 0 0 | -87.053 | 0 | -7.0161 | -38.4623 | -87.053 | QC'd by Microsource |